48
Participants
Start Date
October 1, 2021
Primary Completion Date
August 1, 2025
Study Completion Date
August 1, 2026
Navitoclax
P.O 50mg QD Q28 days for 2 cycles pre-transplant Up to 50mg QD Q28 days maintnance post-transplant based on MTD
Venetoclax
P.O 400mg QD Q28 days for 2 cycles pre-transplant Up to 400mg QD Q28 days maintnance post-transplant based on MTD
Rabin Medical Center, Petah Tikva
Sheba Medical Center, Ramat Gan
Soroka Medical Center, Beersheba
Rambam Health Care Campus, Haifa
Tel Aviv Sourasky Medical Center, Tel Aviv
Shaare Zedek Medical Center, Jerusalem
Rabin Medical Center
OTHER
Sheba Medical Center
OTHER_GOV
Rambam Health Care Campus
OTHER
Tel Aviv Medical Center
OTHER
Soroka University Medical Center
OTHER
Shaare Zedek Medical Center
OTHER
Hadassah Medical Organization
OTHER
Israeli Medical Association
OTHER